Erbitux 100 MG/50 ML vial 50ML
Ended Awarded Last action
- Contract number
- SPE2DR26F0B0N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,612
Award facts
- Contract value 100% obligated
- $21,611.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $21,611.60 to AmerisourceBergen Drug Corp on January 30, 2026, for the supply of Erbitux (cetuximab) 100 mg/50 mL vials. This firm fixed-price, non-set-aside delivery order is scheduled for completion by February 2, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.999 billion through December 31, 2031, which serves as the primary vehicle for supplying comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, operating under its parent Cencora, Inc., is a major pharmaceutical distributor critical to federal medical procurement, particularly for military and veteran healthcare systems. The company consistently competes on a full and open basis for federal contracts and has demonstrated capability across diverse therapeutic domains including oncology medications such as Erbitux. This delivery order represents a routine task order under the broader DLA pharmaceutical supply chain vehicle, supporting the agency's mission to provide essential medications and medical commodities to Defense Health Agency facilities, the U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F0B0N?
SPE2DR26F0B0N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26F0B0N worth?
The government has obligated $21,612 on SPE2DR26F0B0N.
Is contract SPE2DR26F0B0N an order under another contract?
Yes. SPE2DR26F0B0N is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F0B0N competed?
The extent of competition for SPE2DR26F0B0N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award